Poster Presentation & Discussion 13:00-15:00 Oct. 4 (Wed) / Oct. 5(Thu) (Poster Exhibition Room) Depression Lessons Learned from STAR-D Program
Sidney Zisook (USA) Department of Psychiatry, University of California San DiegoA case of Shy-Drager syndrome with depression: anti-depressive and adverse effects of m-ECT
Takaaki Abe (Japan) Department of Psychiatry, School of Medicine, Jichi Medical School, Tochigi, JapanMEDICAL BURDEN IN LATE-LIFE BIPOLAR DISORDER AND UNIPOLAR DEPRESSION Ariel G. Gildengers (USA) Department of Psychiatry, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA Attenuated caudate activation in elderly depression within 1-year after remission:a fMRI study
Hiroshi Takami (Japan) Department of Psychiatry and Neurosciences, Graduate School of BiomedicalSciences, Hiroshima University, Hiroshima, JapanSuccessful use of methylphenidate for depression in severely medically ill elderly patients Ken Wada (Japan) Department of Psychiatry, Hiroshima City Hospital Clinical features of The Hospitalized Elderly Patients with Bipolar Disorders in Korea Han Yong Jung (Korea) Dept. of Psychiatry, Soonchunhyang University Bucheon Hospital, Bucheon, Korea Expressions of SR protein splicing factors in patients with mood disorders Toshio Watanuki (Japan) Neuropsychiatry, Yamaguchi University Graduate School of Medicine, Ube, Japan Risperidone in the treatment of elderly psychotic depression Makiko Goto (Japan) Department of Psychiatry, University of Occuoational and Environmental Health, Kitakyushu, JAPAN Effect of bromocriptine in the elderly patient with refractory depression Michiko Fujimoto (Japan) Division of Neuropsychiatry, Department of Neuroscience, Yamaguchi University School of Medicine Depression Profile Between Institutionalized Care and Home Care of Elderly in Makassar, Indonesia. Andi J. TANRA (Indonesia) Department of Psychiatry, Hasanuddin University, Makassar, Indonesia The expression and function of CREB in T lymphocytes of geriatric depressed patients Jae Won Chung (Korea) The Department of Psychiatry,Samsung Medical Center,Sungkyunkwan University School of Medicine, Seoul, Korea Altered expression of cell adhesion molecules in mood disorder patients Yusuke Wakabayashi (Japan) Division of Neuropsychiatry, Department of Neuroscience, Yamaguchi University Graduate School of Medicine Pharmacological treatment of late-onset bipolar disorder: a retrospective chart review Yasuya Nakatoh (Japan) Department of Psychiatry, Municipal Muroran Genreral Hospital, Hokkaido, Japan Depressive symptoms across four ethnic groups in the Multi-Ethnic Study of Atherosclerosis
Hochang B. Lee (USA) Johns Hopkins University, Baltimore, MD.Prevalence of late life depression; results from the Korean Longitudinal study of Health and aging
Joon-Hyuk Park (Korea) Department of neuropsychiatry, Seoul National University Bundang Hospital,Seongnam, Kyunggi-do, KoreaPrediction of antidepressant response via the alteration of CREB (Preliminary reports) Boram Cha (Korea) Department of Neuropsychiatry, Samsung Medical Center, Sungkyunkwan University School of Medicine International College of Geriatric Psychoneuropharmacology 2006Quantitative and Qualitative Comparison of Late-onset MDD and Early-onset MDD Ki-Woong Kim (Korea) Department of neuropsychiatry, Seoul National University Bundang Hospital, Seongnam, Kyunggi-do, Korea Regional cerebral blood flow in depressed patients with cognitive impairment Amane Tateno (Japan) Department of Neuropsychiatry, Nippon Medical School, Tokyo, Japan Alterations of CREB in lymphocyte of depressed patients during 24 weeks of antidepressant treatment Young-Ran Song (Korea) Department of Neuropsychiatry, Samsung Medical Center, Sungkyunkwan University School of Medicine Regulation of adult neurogenesis by traumatic experiences in mice Keisuke Tamaki (Japan) Mol. Pharm., Kanazawa Univ. Grad. Sch. of Nat. Sci. and Technol., Kanazawa, Japan Seven cases with late-life depression who responded a Cilostazol combination therapy Hajime Baba (Japan) Department of Psychiatry, School of Medicine, Juntendo University, Tokyo, Japan Executive Functions in Remitted Phase of Late Life Depression Kanako Baba (Japan) Department of Psychiatry, Juntendo University School of Medicine, Tokyo, Japan Two cases of new-onset depression in patients over age 90 Hideo Kobayakawa (Japan) Department of Psychiatry, National Hospital Organization (NHO) Kure Medical Center Efficacy and Safety of Mirtazapine (Remeron) in Elderly Depressed Patients Byeong Kil Yeon (Korea) Dept. of Psychiatry, Kangdong Sacred Heart Hospital Hallym University Organic factors may affect cognitive function in remitted state and clinical features in depression
Yoshiyuki Nakano (Japan) Department of Psychiatry Juntendo University School of Medicine, Tokyo, JapanMemory disturbance during remitted phase in patients with late-life depression. Hitoshi Maeshima (Japan) Department of psyciatry juntendo university school of medicine, Japan ELECTROCONVULSIVE THERAPY REDUCES PAIN IN POSTHERPETIC NEURALGIA Tatsuo Sameshima (Japan) The Department of Neuropsychiatry, University of Tokyo, Tokyo, Japan Vascular Depression, Stroke Is there an association between neurocardiovascular instability (NCVI) and depression? Jonathan Richardson (UK) Institute for Ageing and Health, Methylphenidate was effective for senile treatment-resistant vascular depression: Two cases report
Akio Mantani (Japan) Kamo Psychiatry Medical Center, Hiroshima, JapanEarly thrombolytic treatment of acute ischemic stroke screened with a prehospital stroke scale Kenichi Iijima (Japan) Department of Neurology, Shimane University School of Medicine The effects of nicergoline on post-stroke apathy kazunori okada (Japan) Department of Neurology, Oda Municipal Hospital A case of vascular depression successfully treated with paroxetine and low dose of risperidone
Wakako Umene (Japan) Depertment of Psychiatry, University of Occupational and Enviromental Health,Kitakyushu, JAPANFrontal executive function tests and regional cerebral blood flow Kenichi Iijima (Japan) Department of Neurology, Shimane University School of Medicine Coronary Artery Disease Burden In Depressed Elderly Patients Rebecca A. Drayer (USA) University of Pittsburgh Can Clinical Markers of Cerebrovascular Disease Predict Treatment Response in Late-Life Depression? EM Whyte (USA) University of Pittsburgh Sleep The prediction of long-term response of donepezil using the change of REM sleep on AD patients.
Soichi Mizuno (Japan) Department of Psychiatry, Mihara Hospital, Hiroshima, JapanEffect of donepezil on sleep and activity in Alzheimer's disease: actigraphic assessment Program
Junya Tsukada (Japan) Department of Psychiatry,Fukuoka University School of Medicine,JapanPresynaptic dopaminergic dysfunction in patients with restless legs syndrome Jong-Min Kim (Korea) Departments of Neurology, Seoul National University Bundang Hospital, Seongnam, Korea Cognitive changes associated with REM sleep Behaviour Disorder Seok-Bum Lee (Korea) Department of neuropsychiatry, Seoul National University Bundang Hospital, Gyeoggido, Korea Neuropsychological assessment in Restless Legs syndrome(RLS) Ki-Woong Kim (Korea) Department of neuropsychiatry, Seoul National University Bundang Hospital, Gyeoggido, Korea Controversial efficacies of the SSRI and Tandospirone in RBD: a case report Hironori Mitsuya (Japan) Department of Neuropsychiatry, University of Fukui Sleep Disordered Breathing is Associated with White Matter Lesions in Older Adults. Elana Miller (USA) Stanford University, Stanford, CA Interaction of sleep apnea, cortisol and APOE on cognition in older adults Carmen M. Schroder (USA) Department of Psychiatry and Behavioral Sciences, Stanford University, Stanford Shizophrenia, Neuroleptics Neuroimaging Characteristics of Very-late-onset Schizophrenia-like Psychosis Mitsuru Suzuki (Japan) Department of Neuropsychiatry, Iwate Medical University, Morioka Japan The roles of organic cation transporter-3 on the effect of methamphetamine in rats Kiyoyuki Kitaichi (Japan) Department of Pharmacology, Faculty of Pharmaceutical Sciences, Nagasaki International University, Nagasaki, Japan Maintenance modified electroconvulsive therapy for an elderly patient with recurrent catatonia.
Shin'Ya Tayoshi (Japan) Department of Psychiatry, Institute of Health Bioscience, The University ofTokushima Graduate School, JapanSix cases of elderly patients with psychotic feature refractory to drug therapy but response to ECT
Shin'Ya Tayoshi (Japan) Department of Psychiatry, Institute of Health Bioscience, The University ofTokushima Graduate School, JapanRelationship between dose and ECG findings of patients on antipsychotics in the long term Yuichiro Tsutsumi (Japan) Ongata Hospital, Tokyo, Japan. Objective and subjective assessments regarding EPS and oversedation of geriatric Schizophrenia
Yuichiro Tsutsumi (Japan) Ongata Hospital, Tokyo,JapanPossible antipsychoric effects of minocycline in patients with schizophrenia Tsuyoshi Miyaoka (Japan) Department of Psychiatry, Shimane University School of Medicine, Izumo, Japan The optional argorithm for the elderly schizophrenic patients in the Chiba University Hiroyuki Watanabe (Japan) Department of Psychiatry, Graduate School of Medicine, Chiba University Efficacy of perospirone on the elder inpatients with delusional disorder Koji Kusaka (Japan) Department of Psychiatry, Yoshida General Hospital, Hiroshima, Japan International College of Geriatric Psychoneuropharmacology 2006Prescriptions to elderly patients with schizophrenia in a psychiatric hospital in Japan Hideaki Katagiri (Japan) Mihara Hospital, Hiroshima, Japan Cognitive functioning and psychotropic drug prescription in geriatric schizophrenia patients Go Okada (Japan) Mihara Hospital, Japan Zonisamide affords a considerable relief to tardive dyskinesia Kazutoyo Inanaga (Japan) Chikusuikai Hospital, Institute for Neuroinformation and Arao Mental Hospital Delirium The practice of treatment for delirium in Japan Kotaro Hatta (Japan) Department of Psychiatry, Juntendo University School of Medicine, Tokyo, Japan Successful treatment with atypical neuroleptics for delirium in terminally-ill cancer patients Hideto Shinno (Japan) Department of Psychiatry, Shimane University, Izumo, Japan A Validation Study for the Korean Version of Delirium Rating Scale-Revised-98 (K-DRS-98) Ji_Young Yun (Korea) Department of Psychiatry, Medical college, Chungnam University, Daejeon, Korea An open-label study of the usefulness of perospirone (atypical antipsychotic) in senile delirium
Yuichiro Tsutsumi (Japan) Ongata Hospital, Tokyo, JapanAn open-label study of quetiapine for delirium Benchalak Maneeton (Thailand) Department of Psychiatry, Chaing Mai University, Chaing Mai, Thailand Use of atypical antipsychotics in elderly patients with delirium Keiko Nakano (Japan) Department of Psychiatry, National Hospital Organization (NHO) Kure Medical Center Aging, Clinical Evaluation, etc. Burnout and Psychiatric morbidity among Physicians engaged in End-of-life Care for Cancer Patients. Mariko Asai (Japan) Psychiatry Division, National Cancer Center Hospital, Tokyo, Japan Multidimensional Assessment of Pain and Distress in Patients with Psychotic Disorders Phil Whang (USA) University of Medicine and Dentistry of New Jersey, Newark, New Jersey, USA The new caregivers of the 21st century Liat Ayalon (Israel) Bar Ilan University Gender difference on caregivers burden in early-onset Alzheimers disease Kuroda Maki (Japan) Department of Psychiatry, Juntendo School of Medicine, Tokyo, Japan Correlation between Metabolic Syndrome and Cognition in the Elderly Chang Hyung Hong (Korea) Department of Psychiatry, College of Medicine, Yonsei University, Seoul, Korea Effect of ApoE Genotype on the Relationship between Nutritional Risk and Cognition in the Elderly
Chang Hyung Hong (Korea) Department of Psychiatry, YUMC, Seoul, KoreaThe survey of psychotropics and the risk for falls in inpatients Akira Yoshimi (Japan) Divis Clin Sci & Neuropsychopharm, Fac Pharm, Meijo Univ Psychogeriatric Services for Outpatients with Long-term Care Insurance at a Clinic Norihiko Wakae (Japan) Wakae Clinic,Kobe,Japan Age-related emotionality is initiated by astrogliosis due to cortical δ -opioid receptor dysfunction
Naoko Kuzumaki (Japan) Department of Toxicology, Hoshi University School of Pharmacy andPharmaceutical Sciences, 2-4-41 Ebara, Shinagawa-ku, Tokyo 142-8501, JapanThe saliva level of the noradrenaline metabolite and a mental function in a general population. Itaru Watanabe (Japan) Department of Psychiatry,Faculty of Medicine,Saga University.Saga,Japan Does subthrehold depression influence on cognition and quality of life in older adults? Joon-Hyuk Park (Korea) Department of neuropsychiatry, Seoul National University Bundang Hospital, Seongnam, Kyunggi-do, Korea Age-related declines of semantic fluency and phonemic fluency Ji Woon Jeong (Korea) Department of Neuropsychiatry, Seoul National University Bundang Hospital, Seongnam, Korea Development of Severe Cognitive Impairment Rating Scale (SCIRS) Program
Jin-Yeong Choe (Korea) Department of Neuropsychiatry, Seoul National University Bundang Hospital,Seongnam, Kyunggi-do, Korea Aging of Frontal Function: Results of Korean Longitudinal Study on Health and Aging (KLoSHA)
Eun-Ae Choi (Korea) Department of neuropsychiatry, Seoul National University Bundang Hospital,Seongnam, Kyunggi-do, Korea Serum methylglyoxal (MG) is negatively associated with cognitive function in the very elderly Michal Schnaider Beeri (USA) Mount Sinai School of Medicine, New York, NY PATTERNS OF PSYCHIATRIC DIAGNOSIS IN A TERTIARY PSYCHOGERIATIC CLINIC IN IBADAN, NIGERIA Olorunyomi E Olowosegun (Nigeria) Department of Psychiatry, University College Hospital, Ibadan, Nigeria Decreased recognition of facial affects in elderly Chung Tai Lee (Korea) Uijongbu St. Mary's Hospital, Uijongbu, Gyeonggido, Korea Polyunsaturated fatty acids and cognitive deficits in elderly people living in a local community. GuangYing Li (Japan) Department of Psychiatry, Faculty of Medicine,Saga University, Saga,Japan COMT Genotype, Gender and Cognition in Community-Dwelling, Older Adults. Nate A. Way (USA) Stanford University, Stanford, CA, USA Higher Waking Cortisol Is Associated with Lower Hippocampal Volume in Older Adults Roopa M. Mahadevan (USA) Stanford University, Stanford, CA Validity of the IQCODE-K in the Community Population Dong-W Lee (Korea) Department of Psychiatry, Sanggye Paik Hospital, Inje University Japanese cancer patients' preferences for physicians' communication style when receiving bad news. Maiko Fujimori (Japan) Psycho-Oncology Division, Research Center for Innovative Oncology, National Cancer Center Hospital East Association between serum lipids concenration and cognitive functions in the eldery. Satoshi Tanimukai (Japan) Department of Neuropsychiatry, Institute of Clinical Medicine, University of Tsukuba Sexual difference of P300 latency in elderly subjects without dementia Sadatoshi Kurosu (Japan) Department of Pychoneurology, school of Medicine, Fukushima medical university Mild Cognitive Impairment The Effects of Donepezil on IADLs in Elders with Bipolar Disorder and Mild Cognitive Impairments
Ariel G. Gildengers (USA) Department of Psychiatry, University of Pittsburgh School of Medicine, Pittsburgh,PA, USAShould subjective cognitive complaints be part of the diagnosis of MCI? Melissa J. Slavin (Australia) School of Psychiatry, The University of New South Wales Changes and Predictors of Memory of Mild Cognitive Impairment in the Elderly Shifu Xiao (China) Geriatric Psychiatry Dept., Shanghai Mental Health Center, Shanghai Jiaotong University, Shanghai, China International College of Geriatric Psychoneuropharmacology 2006Spatial memory function decline in aging and MCI - a virtual radial arm maze study Kyung Ryeol Cha (Korea) Department of Psyciatry, Yonsei University College of Medicine, Seoul, Korea Using Everyday Memory Checklist in Japanese Version to Assess Patients with Early Dementia or MCI Yaping Wang (China) Medical Psychology Department, Second Affiliated Hospital, Xi'an Jiaotong University China Wechsler Memory Scale-Revised (WMS-R) and MRI voxel-based morphometry in MCI Nobuo Furuta (Japan) National Center of Neurology and Psychiatry, Tokyo, Japan Sleep and Neurocognitive Function in Mild Cognitive Impairment (MCI) Patients Jung H Lee (Korea) Dept. of Psychiatry, Kangwon National University Hospital, Chuncheon, Korea Parkinson Disease Protective effect on Dopaminergic Neurons by Serofendic Acid in hemi-parkinsonian rats Yoshihisa Kitamura (Japan) Dept. of Neurobiol., 21st Century COE Program, Kyoto Pharm. Univ. Alteration of DJ-1-distribution in 6-OHDA-injected rat model and its neuroprotective effect Takashi Yanagida (Japan) Dept. of Neurobiol., 21st Century COE Program, Kyoto Pharm. Univ. Upregulation of Protease-Activated Receptor-1 in Astrocytes in Parkinson Disease Yuri Shiota (Japan) Department of Neurology, Shimane University, Shimane, Japan Parkinsonism-inducing substances inhibit gap junction and activate ERK 1/2 Asami Kawasaki (Japan) Grad.Sch.Biomed.Sci.,Hiroshima Univ Evaluation of anhedonia in Japanese patients with Parkinson disease Toshihide Harada (Japan) Department of Health Services Management, Hiroshima International University, Higashihiroshima, Hiroshima, Japan ATP reduction leads to cell death caused by a Parkinson s disease-related endogenous neurotoxin.
Yuichi Yokoyama (Japan) Grad. Sch. Biomed. Sci., Hiroshima Univ.Changes of cognitive functions and mental states during STN-DBS in Parkinson,s disease. Aono Michitaka (Japan) Department of Psychiatry, Jounan Hospital, Tokushima, Japan Saccadic inhibition and cognitive impairment in PD S Van Stockum (New Zealand) Van Der Veer Institute P62 Aggregations Widespread in the Brain with Amyotrophic Lateral Sclerosis with Dementia Masanori Hiji (Japan) Tsuchiya General Hospital, Hiroshima, Japan GABAergic signals in murine neural progenitor cells Masaki Fukui (Japan) Kanazawa Univ.Grad.Sch.Nat.Sci.Tech. Prediction of disease state in Parkinson disease by motor versus non-motor tests Nicolaas I Bohnen (USA) Dept. Radiology, University of Michigan, USA Dementia Treatment Lithium and dementia: a preliminaly study Takeshi Terao (Japan) Department of Neuropsychiatry, Oita University Faculty of Medicine, Oita, Japan Efficacy and Safety of Memantine in Moderate-to-Severe Dementia Patients in Korea Inn-Sook Ahn (Korea) Department of Psychiatry, Samsung Medical Center, Seoul, Korea Adequate Use of Psychotropic Agents at Healthcare Facility for Elderly in Japan Hitoshi Misawa (Japan) The Department of General Medicine, Tokyo-Kita Social Insurance Hospital, Tokyo, Japan Three Cases of Quetiapine Augmentation for Donepezil-Refractory Hallucinations in Lewy Body Dementia Nobuyosi Ishii (Japan) Department of Neuropsychiatry,Oita university faculty of medicine,Oita,Japan Sex Hormones and Mental Health Outcomes in Later Life Almeida P. Osvaldo (Australia) Unite of Geriatric Psychiatry, University of Western Australia & Royal Perth Hospital Amisulpride vs Risperidone Treatment for BPSD in Patients with Dementia of Alzheimer Type Program
Hyun-Kook Lim (Korea) Department of Psychiatry, Kangnam St. Mary's Hosp., The Catholic University ofKorea, College of Medicine, Seoul, KOREAEffects of Galantamine on Attention of Patients ith Alzheimer's Disease and Mixed Dementia Ji Hea Yun (Korea) Samsung Biomedical Research Institute, Samsung Medical Center, Seoul, Korea A case of DLB in which perospirone improved the symptoms of visual hallucinations Kiwamu Hiroyasu (Japan) Department of Neuropsychiatry, Kanazawa Medical University, Uchinada, Ishikawa, Japan The use of antipsychotics for BPSD of oldest-old Alzheimer disease patients Hideki Ueno (Japan) Dep. of Psy., Tokyo Metropolitan Matsuzawa Hospital Donepezil in advanced Dementia with Lewy Bodies Sanjeet Pakrasi (UK) Institute of Ageing and Health Development of the Korean version of behavioral rating scale for dementia (BRSD-K) Jong_Chul Youn (Korea) Kyunggi Provincial Hospital for the Elderly, Kyunggi-do, Korea A microarray-based strategy for prediction of treatment efficacy Rosanne Di Pietrantonio (USA) VA Healthcare System, Long Beach, USA Successful treatment of dementia with lewy bodies (DLB) using low-dose donepezil Yasutaka Fujita (Japan) Department of Psychiatry, National Hospital Organization(NHO) Kure Medical Center, Hiroshima, Japan Three cases of paroxetine responsive fronto-temporal lobar degeneration (FTLD) Keiichiro Nishida (Japan) Department of Neuropsychiatry, Kansai Medical University, Osaka, Japan Effect of Investigator Training on Signal Detection Steven Targum, MD (USA) United BioSource Corporation Combination therapy of risperidone and trazodone in Dementia with Lewy bodies Yoshie Miyake (Japan) Department of Psychiatry and Neurology, Hiroshima Prefectural Hospital Alzheimer Disease; Clinical A Variant of the Sigma Receptor Type 1 Gene Is a Protective Factor for Alzheimer's Disease Naohiko Uchida (Japan) Department of Neuropsychiatry, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences Immunohistochemical study of the serotonin receptor in the hippocampus of Alzheimer's disease.
Katsuyoshi Mizukami (Japan) Department of Psychiatry, University of Tsukuba, Ibaraki, JapanMeasurement of Serum Homocysteine in Korean Patients with Dementia Jin Sook Cheon (Korea) Department of Neuropsychiatry, Kosin University College of Medicine, Busan, Korea Frontal intermittent rhythmic delta activity(FIRDA) in Alzheimer's disease. Masaki Shiozawa (Japan) Kikuchi National Hospital For Mental and Nervous Disorders, Kumamoto, Japan Using cerebrospinal fluid beta-amyloid (1-42), tau and phospho-tau to diagnose Alzheimer's disease haibo xue (China) shanghai mental health center, shanghai Alzheimer disease and cerebrovascular disease, links with Amyloid β protein Kie Honjo (Canada) Kunin-Lunenfeld Applied Research Unit, Baycrest International College of Geriatric Psychoneuropharmacology 2006Increased expression of cell cycle regulatory protein in patients with Alzheimer's disease Young M. Lee (Korea) The department of Psychiatry, Samsung Medical Center, Seoul, Korea Altered cell viability and proliferation activity of peripheral lymphocytes in Alzheimer's disease Jun M. Ha (Korea) The Department of Psychiatry, Samsung Medical Center, Seoul, Korea Efficiency of five scoring methods of clock drawing test in screening Alzheimer disease IL HAN CHOO (Korea) Department of Neuropsychiatry and Clinical Research Institute, Seoul National University Hospital, Seoul, Korea Apolipoprotein E genotype and white matter integrity in early stage Alzheimer's disease: DTI study
Dong Y. Lee (Korea) Department of Neuropsychiatry, Seoul National University Hospital, Seoul, KoreaHigh frequency of open-angle glaucoma in Alzheimer disease patients Hiroki Tamura (Japan) Department of Epidemiology, Research Institute for Radiation Biology and Medicine, Hiroshima University, Japan Cell cycle regulatory proteins in peripheral lymphocytes of patients with Alzheimer disease Hyeran Kim (Korea) Department of Psychiatry, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea The exchange of Cyclin B and Cyclin D in peripheral lymphocytes from the patients with AD patients YOUNG AH KWON (Korea) Department of Psychiatry, Samsung BioMedical Research Institute The effect of Spaced Retrieval Training(SRT) on Memory Can be generalized in Alzheimer disease
Seok-bum Lee (Korea) Department of neuropsychiatry, Seoul National University Bundang Hospital,Gyeoggido, KoreaThe Primary Study of the Serotonin Platelet Level in Patients with Dementia Xia Li (China) The Third Ward of Geriatric Department of Shanghai Mental Health Centre. Shanghai, China Serum Biomarker Panels Specific to AD Pathology and Viability of Cholinergic Neurons Yasuyo Yamazaki (Canada) Phenomenome Discoveries Inc, Saskatoon, Canada Neuronal RNA oxidation in preclinical and very mild Alzheimer disease Akihiko Nunomura (Japan) Department of Psychiatry and Neurology, Asahikawa Medical College, Asahikawa, Japan Increased temporal cortex cyclooxygenase-2 in Alzheimer's disease Akira Tamaoka (Japan) Department of Neurology, Institute of Clinical Medicine, University of Tsukuba, Tsukuba, Japan APOE Genotype Moderates the Impact of Cortisol and DHEA on Cognition in Alzheimers Disease Patients Nichole Kryla (USA) Stanford University, Stanford, CA Alzheimer Disease; Neuroimaging Left lateralized hypoperfusion in depressed AD patients: A SPECT study Keisuke Shibata (Japan) Department of Psychiatry, Graduate School of Medicine, Kyoto Prefectural University of Medicine, Kyoto, Japan Working Memory Deficits in Patients with Dementia of the Alzheimer's type: fMRI investigation Chul Lee (Korea) Department of Psychiatry, Kangnam St. Mary's Hospital, The Catholic University of Korea, College of Medicine, KOREA The voxel-based morphometry of gray matter reduction in patients with dementia of Alzheimer's type Chang-Uk Lee (Korea) Department of Psychiatry, Kangnam St. Mary's Hosp., The Catholic University of Korea, College of Medicine, KOREA The effects of Donepezil on hippocampal atrophy assessed by new MRI software in Alzheimer's disease kazunori Okada (Japan) Department of Neurology, Oda Municipal Hospital MUSCARINIC RECEPTOR SPECT IN ALZHEIMERS DISEASE AND DEMENTIA WITH LEWY BODIES
Sanjeet Pakrasi (UK) Institute of Ageing and HealthA case of semantic dementia treated with fluvoxamine and studied longitudinally by SPECT. Program
Koji Ogomori (Japan) Department of Psychiatry, School of Medicine, Fukuoka University, Fukuoka, JapanChanges of cerebral glucose metabolism in Alzheimer,s disease patients with paranoid delusion Jong_Chul Youn (Korea) Kyunggi Provincial Hospital for the Elderly, Yongin, Kyunggi-do, Korea Neuronal nicotinic acetylcholine receptors: a target for PET radiotracer development Winnie Deuther-Conrad (Germany) Institute of Interdisciplinary Isotope Research Depression and White Matter Changes of the Brain MRI in Dementia Patients Seong Yoon Kim (Korea) Department of Psychiatry, Asan Medical Center, Alzheimer Disease; Basic Cerebrolysin reduces the human brain kynurenine aminotransferase I and II activities Halina Baran (Austria) Institute of Physiology, DNS, VM University Vienna, Vienna, Austria TNF-α is required for protein nitration induced by Aβ Tursun Alkam (Japan) Department of Neuropsychopharmacology and Hospital Pharmacy, Nagoya University, Nagoya, Japan A unique gene expression signature discriminates FAD mutation carriers from their wild-type siblings Hayao Ebise (Japan) Dainippon Sumitomo Pharma Co., Ltd. Gamma-Schisandrin Inhibits Expression of Amyloid beta-protein in M146L Cell Huanmin Luo (China) Neuropharmacological Research Laboratory, College of Pharmacy, Jinan University Regulatory Factors to Microglial Role in Alzheimer's Disease Brain Kazuyuki Takata (Japan) Dept. Neurobiol., 21st Century COE Program, Kyoto Pharm. Univ. Developmental alterations in expression of WASP family in postnatal rat brain Daiju Tsuchiya (Japan) Dept. Neurobiol., 21st Century COE Program, Kyoto Pharm. Univ. Aggregate formation of mutant γPKC found in SCA14 impairs ubiquitin-proteasome system Takahiro Seki (Japan) Deptartment of Molecular and Pharmacological Neuroscience, Graduate School of Biomedical Sciences, Hiroshima University Influence of Amyloid-β aggregational state on microglial production of TNF-α Takahiro Kato (Japan) Department of Neuropsychiatry, Graduate school of Medical Science, Kyushu University, Fukuoka, Japan Cannabinoid system serves as a modulator of cognitive impairment arising withdrawal of MDMA
Yoko Nawata (Japan) Dept. Pharmacol., Faculty Pharm. Sci., Nagasaki Int. Univ., Nagasaki, JapanA novel chemical compound, BIX, suppresses neuronal death via the induction of an ER chaperone. Soshi Kanemoto (Japan) Div. of Mol. Cell. Biol., Dep. of Anat., Faculty of Medicine, University of Miyazaki, Miyazaki, Japan Enhanced accumulation of phosphorylated α-synuclein in transgenic mice expressing APP and PS-1. Tomoko Kurata (Japan) Department of Neurology, Okayama University Graduate School of Medicine, Dentistry and Pharmacy, Okayama, Japan New transgenic tau mouse model with cognitive disturbances Birgit Hutter-Paier (Austria) JSW-Research International College of Geriatric Psychoneuropharmacology 2006
β-SYNUCLEIN DERIVED SMALL PEPTIDES FOR TREATMENT OF ALZHEIMERS DISEASE Manfred Windisch (Austria) JSW-Research Establishment of a p75NTR Transgenic Mouse Model Gert Schwach (Austria) JSW-Research Glutamate tolerance in cultured neurons Yuki Kambe (Japan) Kanazawa University Graduate School of Natural Science and Technology, Ishikawa, Japan Clioquinol itself does not inhibit Hydrogenperoxide formation induced by amyloid-beta peptide
Yoshihito Hayashi (Japan) Department of Psychiatry, Faculty of Medicine, Miyazaki UniversityDesensitization of NMDA receptor channels following repetitive exposure in cultured cortical neurons Noritaka Nakamichi (Japan) Lab Mol Pharmacol, Kanazawa Univ Grad Sch Nat Sci Tech Neural progenitor cells isolated from adult and embryonic mouse hippocampi Sayaka Maeda (Japan) Laboratory of Molecular Pharmacology, Division of Pharmaceutical Sciences, Kanazawa University Graduate School of Natural Science and Technology, Kanazawa, Japan Metabotropic glutamate receptors in murine neural progenitor cells Kohei Yoshida (Japan) Kanazawa Univ.Grad.Sch.Nat.Sci.Tech Signal transduction mediated by metabotropic glutamate receptors in cultured rat cortical neurons
Eriko Honda (Japan) Lab of Mol Pharmacol, Kanazawa Univ Grad Sch of Nat Sci and TechDownregulation by lipopolysaccharide of a glutamine transporter in cultured neocortical astrocytes
Chie Ohnishi (Japan) Lab. Mol. Pharmacol., Kanazawa Univ. Grad. Sch. Nat. Sci. Tech., Kanazawa, JapanInterleukin-18 is a new player in Alzheimer's disease pathogenesis Gianfranco Spalletta (Italian) IRCCS Santa Lucia Foundation, Rome, Italy JSDR Joint Use of the Quality of Life Index among elderly with early-stage dementia Towako Katsuno (Japan) Faculty of Health Sciences, Tokyo Metropolitan University, Tokyo, Japan Aromatherapy can improve the cognitive functions in patients with Alzheimer's disease. Daiki Jimbo (Japan) Section of Environment and Health Science, Department of Biological Regulation, School of Health Science, Faculty of Medicine, Tottori University Yokukansan inhibits memory disturbance, anxiety and neurological symptoms in thiamine- deficient rats Yasushi Ikarashi (Japan) Central Research Laboratory, Tsumura & Co., Ibaraki, Japan CSF orexin levels in patients with PD, DLB, PSP and CBD Kenichi Yasui (Japan) Department of Neurology, Institute of Neurological Sciences, Faculty of Med, Tottori University, Yonago, Japan Parkinson's disease with hallucinations is closely related to PDD in executive dysfunction Keiko Imamura (Japan) Department of Neurology, Institute of Neurological Sciences, Faculty of Medicine, Tottori University, Yonago, Japan Accumulation of phosphorylated alpha-synuclein in the striatum of Lewy body diseases Kimiko Obi (Japan) Department of Neurology, Juntendo University Biochemical analysis of the core structures of wild type and mutant α-synuclein filaments Motokuni Yonetani (Japan) Department of Molecular Neurobiology, Tokyo Institute of Psychiatry, Tokyo, Japan CK2 is the major enzyme in brain that generates PSer129 epitope of α-synuclein Masato Hasegawa (Japan) Department of Molecular Neurobiology, Tokyo Institute of Psychiatry Inhibition of the proteasome activity by alpha-synuclein in SH-SY5Y cells Takashi Nonaka (Japan) Molecular Neurobiology, Tokyo Institute of Psychiatry Small molecule inhibitors of α-synuclein filament assembly Masami Masuda (Japan) Dept. Mol. Neurobiol., Tokyo Inst. of Psychiatr., Tokyo, Japan Effect of α-synuclein on microtubule assembly Takayuki Oikawa (Japan) Dept. Mol. Neurobiol., Tokyo Inst. of Psychiatry, Tokyo, Japan Program Immunohistochemical analysis of proteins related to aging and Alzheimer's disease in the retina
Tadashi Takahashi (Japan) Department of Psychiatry, Juntendo University School of Medicine, Tokyo,JapanAnalysis of cerebrospinal fluid glycoprotein as new biomarker of Alzheimer's disease Miyako Taniguchi (Japan) Department of Biological Regulation, Faculty of Medicine, Tottori University Mechanism of glycosylation using of Con A in Alzheimer's disease Yuki Hashimoto (Japan) Department of Biological Regulation, Faculty of Medicine, Tottori University, Yonago, Japan Genetic association of dynamin-binding protein gene with late-onset Alzheimer's disease Ryozo Kuwano (Japan) Niigata Univ. Choroid plexus proteome analysis in Alzheimer disease Hiroyasu Akatsu (Japan) Choju Med. Inst., Fukushimura Hosp. Aβ and tau form soluble complexes that may promote self aggregation of both into the insoluble forms Tetsuaki Arai (Japan) Dept. of Psychogeriatrics, Tokyo Inst. of Psychiatry Identification of Alzheimer-specific amyloid beta-derived products recognized by panel of antibodies Mutsufusa Watanabe (Japan) Alzheimer's Dis. Res. Group, Mitsubishi Kagaku Inst. Life Sci., Tokyo, Japan Increased expression of Toll like receptor 3 in amyloid beta-treated cells and Alzheimer's brain Toshihisa Tanaka (Japan) Division of Psychiatry, Osaka University Graduate School of Medicine Effects of apoE isoforms on Aβ concentration and lipid composition in the brain LDM domains Maho Morishima (Japan) Department of Neuropathology, Faculty of Medicine, University of Tokyo, Tokyo, Japan The interaction of α1-chimaerin protein with β-amyloid in culture cells Ikuo Tooyama (Japan) Molecular Neuroscience Research Center, Shiga University of Medical Science, Shiga, Japan In vivo imaging of amyloid plaques in the brain: [11C]BF-227 PET study. Nobuyuki Okamura (Japan) Department of Pharmacology, Tohoku University School of Medicine, Sendai, Japan Evaluation of gray and white matter changes in Mild Cognitive Impairment using 3T MRI Satoshi Takahashi (Japan) Department of Neurology, Iwate Medical University, Iwate, Japan The evidence of neural network disruption in mild cognitive impairment Okumura Ayumi (Japan) Chubu medical center,Kizawa memorial hospital, Gifu, Japan
SIGMA-ALDRICH MATERIAL SAFETY DATA SHEET Date Printed: 08/14/2007 Date Updated: 01/26/2006 Version 1.7 Section 1 - Product and Company Information Product Name Tetracycline hydrochloride, meets USP testing specifications Product Number T4062 Brand SIAL Company Sigma-Aldrich Canada, Ltd Address 2149 Winston Park Drive Oakville ON L6H 6J8 CA Technical Phone: 9058299500 Fax: 9058299292 Emergency Pho
NAME OF THE MEDICINAL PRODUCT BELOGENT® cream BELOGENT® ointment betamethasonum, gentamicinum QUALITATIVE AND QUANTITATIVE COMPOSITION 1 g of cream contains 0.5 mg of betamethasone in the form of dipropionate and 1 mg of gentamicin in the form of sulphate. 1 g of ointment contains 0.5 mg of betamethasone in the form of dipropionate and 1 mg of gentamicin in the form of sulphate.